Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Fluorescein-Guided Resection in Pediatric Tumors
NCT03752203Terminated
- Sponsor
- University of Colorado Denver
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluorescein in central nervous system tumor, sponsored by University of Colorado Denver. Primary endpoints: Percent of Tumor Resected: Intracranial Lesions up to 6 weeks and Percent of Tumor Resected: Spinal Lesions up to 6 weeks. Started Aug 2021; status: terminated.
02
Drugs
fluorescein
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on NCT03752203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752203.